11 February 2021 - Many countries use independent review boards to balance innovation and profit.
The United States receives worthwhile innovation (and also some not so worthwhile innovation) as a result of its high drug prices.
But there is no consensus about what the “right” level of innovation should be, so it’s unclear how much to lower or raise prices.